Skip to content
10-Q

Quarterly Report

BridgeBio Pharma, Inc. BBIO

0001743881-25-000012

← back to feed
Filed
Oct 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 21, 2025 192.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 191.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 190.85M sh
Shares Diluted Q3 2025 · Sep 30, 2024 188.51M sh
Shares Diluted Q3 2025 · Sep 30, 2024 184.95M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $48.28M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $1.06M
Capex Q3 2025 · Sep 30, 2024 $886K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$389.49M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$325.4M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $642.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $681.1M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $266.32M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.93B
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.47B
Current Liabilities Q3 2025 · Sep 30, 2025 $216.6M
Current Liabilities Q3 2025 · Dec 31, 2024 $154.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.92B
Total Liabilities Q3 2025 · Dec 31, 2024 $2.38B
Current Assets Q3 2025 · Sep 30, 2025 $839.38M
Current Assets Q3 2025 · Dec 31, 2024 $720.69M
Total Assets Q3 2025 · Sep 30, 2025 $998.25M
Total Assets Q3 2025 · Dec 31, 2024 $919.34M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.95
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.79
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.86
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.46
Eps Basic Q3 2025 · Sep 30, 2025 −$0.95
Eps Basic Q3 2025 · Sep 30, 2025 −$2.79
Eps Basic Q3 2025 · Sep 30, 2024 −$0.86
Eps Basic Q3 2025 · Sep 30, 2024 −$1.46
Sga Expense Q3 2025 · Sep 30, 2025 $137.62M
Sga Expense Q3 2025 · Sep 30, 2025 $373.14M
Sga Expense Q3 2025 · Sep 30, 2024 $68.82M
Sga Expense Q3 2025 · Sep 30, 2024 $194.15M
Rd Expense Q3 2025 · Sep 30, 2025 $112.87M
Rd Expense Q3 2025 · Sep 30, 2025 $335.54M
Rd Expense Q3 2025 · Sep 30, 2024 $120.44M
Rd Expense Q3 2025 · Sep 30, 2024 $376.11M
Operating Income Q3 2025 · Sep 30, 2025 −$145.2M
Operating Income Q3 2025 · Sep 30, 2025 −$383.85M
Operating Income Q3 2025 · Sep 30, 2024 −$191.75M
Operating Income Q3 2025 · Sep 30, 2024 −$366.95M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $6.56M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $12.86M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $598K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.79M
Revenue Q3 2025 · Sep 30, 2025 $120.7M
Revenue Q3 2025 · Sep 30, 2025 $347.9M
Revenue Q3 2025 · Sep 30, 2024 $2.73M
Revenue Q3 2025 · Sep 30, 2024 $216.02M